Search Results - "Fulforth, J"
-
1
P127 Inflammatory Bowel Disease-associated colorectal cancers: retrospective cohort study from a tertiary centre surveillance programme over 10 years
Published in Journal of Crohn's and colitis (30-01-2023)“…Abstract Background Patients with IBD have increased risk for developing colorectal cancer (CRC), with poorer survival, compared to those without IBD. Despite…”
Get full text
Journal Article -
2
DOP11 Normalisation of faecal calprotectin within 12 months of diagnosis is associated with a reduced risk of disease progression in Crohn’s disease
Published in Journal of Crohn's and colitis (15-01-2020)“…Abstract Background Faecal calprotectin (FC) demonstrates an excellent correlation with endoscopic inflammation. In addition, a treatment-decision algorithm…”
Get full text
Journal Article -
3
DOP87 Multi-parameter datasets are required to identify the true prevalence of IBD: The Lothian IBD Registry (LIBDR)
Published in Journal of Crohn's and colitis (25-01-2019)“…Abstract Background A recent systematic review reports stabilising or falling IBD incidence in Western countries with an overall prevalence in excess of 0.3%.1…”
Get full text
Journal Article -
4
P575 Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn’s disease: The Scottish ustekinumab cohort
Published in Journal of Crohn's and colitis (15-01-2020)“…Abstract Background Ustekinumab (UST) is an anti-IL12/23 biologic licensed for the treatment of moderate to severe Crohn’s disease (CD). The aims of this study…”
Get full text
Journal Article